Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.

作者: Haimanti Bhattacharya , Debdutta Bhattacharya , SR Ghosal , Subarna Roy , AP Sugunan

DOI: 10.4103/0971-5916.159573

关键词:

摘要: Background & objectives: Andaman and Nicobar Islands of India, home to six primitive tribes, constituting about 10 per cent the total population these have been detected with high endemicity hepatitis B infection. During 2000, a 936 individuals ≤ 45 yr, negative for surface antigen (HBsAg) antibody anti-HBs were vaccinated three doses recombinant DNA vaccine in two villages Car Islands. The present study was undertaken evaluate impact vaccination respect persistence antibodies incidence new infections, prevalence gene mutations among Nicobarese community ten years after vaccination. Methods: Follow up samples collected from 211 who had received back control group 515 non-vaccinated individuals. HBsAg, anti-HBc assay results compared groups. HBV extracted sequenced all detection mutation. Genotyping serotyping viruses performed. Results: showed that 85.3 persons retained protective level individuals, 54.2 presence indicating an exposure overall HBsAg positivity studies reduced 7.4 vaccination. Anti-HBc positive 60.6 57 respectively. Overall breakthrough infection 8.5 predominant genotype serotype circulating tribal populations D ayw3, Interpretation conclusions: this reduction pool carriers because which helped reducing carrier rate also, probably due increase herd immunity source Further need be done long term benefits tribes.

参考文章(26)
V. A. Arankalle, S. C. Sehgal, D. Das, K. M. Murhekar, M. V. Murhekar, Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands. Indian Journal of Medical Research. ,vol. 111, pp. 199- 203 ,(2000)
Elke Wiseman, Melissa A Fraser, Sally Holden, Anne Glass, Bronwynne L Kidson, Leon G Heron, Michael W Maley, Anna Ayres, Stephen A Locarnini, Miriam T Levy, Perinatal transmission of hepatitis B virus: an Australian experience. The Medical Journal of Australia. ,vol. 190, pp. 489- 492 ,(2009) , 10.5694/J.1326-5377.2009.TB02524.X
Fernando de la Hoz, Ligia Perez, Marlen de Neira, Andrew J. Hall, Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. International Journal of Infectious Diseases. ,vol. 12, pp. 183- 189 ,(2008) , 10.1016/J.IJID.2007.06.010
Haimanti Bhattacharya, S R Ghosal, Debdutta Bhattacharya, A P Sugunan, A K Mandal, A Mandal, R C Rao, Impact of hepatitis B immunization among the Nicobarese tribe--antibody titres & seroprotection five years after vaccination. Indian Journal of Medical Research. ,vol. 139, pp. 427- 430 ,(2014)
Helene Norder, Anne-Marie Couroucé, Pierre Coursaget, José M. Echevarria, Shou-Dong Lee, Isa K. Mushahwar, Betty H. Robertson, Stephen Locarnini, Lars O. Magnius, Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes Intervirology. ,vol. 47, pp. 289- 309 ,(2004) , 10.1159/000080872
Sibnarayan Datta, An overview of molecular epidemiology of hepatitis B virus (HBV) in India Virology Journal. ,vol. 5, pp. 156- 156 ,(2008) , 10.1186/1743-422X-5-156
Khomotso V Tsebe, Rosemary J Burnett, Nyiko P Hlungwani, Mbudzeni M Sibara, Philip A Venter, M.Jeffrey Mphahlele, The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine. ,vol. 19, pp. 3919- 3926 ,(2001) , 10.1016/S0264-410X(01)00120-7
Yang Yong-lin, Fu Qiang, Zhang Ming-shun, Cai Jie, Ma Gui-ming, Huang Zu-hu, Cai Xu-bing, Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virology Journal. ,vol. 9, pp. 82- 82 ,(2012) , 10.1186/1743-422X-9-82
M.V Murhekar, K.M Murhekar, V.A Arankalle, S.C Sehgal, Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India. Vaccine. ,vol. 20, pp. 3431- 3435 ,(2002) , 10.1016/S0264-410X(02)00337-7